CORRECTION article

Front. Microbiol., 25 October 2023

Sec. Infectious Agents and Disease

Volume 14 - 2023 | https://doi.org/10.3389/fmicb.2023.1304196

Corrigendum: Identification of novel anti-amoebic pharmacophores from kinase inhibitor chemotypes

  • 1. Department of Chemistry and Chemical Biology, Northeastern University, Boston, MA, United States

  • 2. Center for Tropical and Emerging Global Diseases, University of Georgia, Athens, GA, United States

  • 3. Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, University of Georgia, Athens, GA, United States

  • 4. Department of Comparative Pathobiology, College of Veterinary Medicine, Purdue University, West Lafayette, IN, United States

  • 5. Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena, Italy

  • 6. Instituto de Parasitología y Biomedicina “López-Neyra” Consejo Superior de Investigaciones Científicas (CSIC), Granada, Spain

  • 7. Department of Molecular and Cellular Biology, Kennesaw State University, Kennesaw, GA, United States

Article metrics

View details

2

Citations

1,8k

Views

549

Downloads

In the published article, there was an error in the author list, and author “Claudia Gómez-Liñán” was erroneously excluded. The corrected author list appears below.

Lori Ferrins1*, Melissa J. Buskes1, Madison M. Kapteyn2, Hannah N. Engels2, Suzanne E. Enos2,3, Chenyang Lu4, Dana M. Klug1, Baljinder Singh1, Antonio Quotadamo1,5, Kelly Bachovchin1, Westley F. Tear1, Andrew E. Spaulding1, Katherine C. Forbes1, Seema Bag1, Mitch Rivers1, Catherine LeBlanc1, Erin Burchfield1, Jeremy R. Armand1, Rosario Diaz-Gonzalez6, Gloria Ceballos-Perez6, Raquel García-Hernández6, Guiomar Pérez-Moreno6, Cristina Bosch-Navarrete6, Claudia Gómez-Liñán6, Luis Miguel Ruiz-Pérez6, Francisco Gamarro6, Dolores González-Pacanowska6, Miguel Navarro6, Kojo Mensa-Wilmot7, Michael P. Pollastri1, Dennis E. Kyle2 and Christopher A. Rice2,3,4*

In the original article there was also an error in the Author Contribution section.

The correct author contributions section appears below:

Statements

Author contributions

CR, MB, and LF: conceptualization. LF, MB, MK, HE, SE, CLu, DKl, BS, AQ, KB, WT, AS, KF, SB, MR, CLe, EB, JA, RD-G, GC-P, GP-M, CB-N, CG-L, DG-P, MN, and CR: methodology. CR, DKy, MP, and LF: validation and supervision. LF and CR: formal analysis and writing—original draft preparation. DKy, MP, and LF: resources and funding acquisition. LF, MB, DKl, BS, KB, WT, SB, MK, HE, SE, CLu, CB-N, and CR: data curation. LF, MB, MK, HE, SE, CLu, DKl, BS, AQ, KB, WT, AS, KF, SB, MR, CLe, EB, JA, RD-G, GC-P, RG-H, GP-M, CB-N, CG-L, LR-P, FG, DG-P, MN, KM-W, MP, DKy, and CR: writing—review and editing. All authors contributed to the article and approved the submitted version.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

pathogenic free-living amoeba, Acanthamoeba species, Naegleria fowleri, Balamuthia mandrillaris, kinase inhibitors, cross-screening, hit-identification

Citation

Ferrins L, Buskes MJ, Kapteyn MM, Engels HN, Enos SE, Lu C, Klug DM, Singh B, Quotadamo A, Bachovchin K, Tear WF, Spaulding AE, Forbes KC, Bag S, Rivers M, LeBlanc C, Burchfield E, Armand JR, Diaz-Gonzalez R, Ceballos-Perez G, García-Hernández R, Pérez-Moreno G, Bosch-Navarrete C, Gómez-Liñán C, Ruiz-Pérez LM, Gamarro F, González-Pacanowska D, Navarro M, Mensa-Wilmot K, Pollastri MP, Kyle DE and Rice CA (2023) Corrigendum: Identification of novel anti-amoebic pharmacophores from kinase inhibitor chemotypes. Front. Microbiol. 14:1304196. doi: 10.3389/fmicb.2023.1304196

Received

29 September 2023

Accepted

02 October 2023

Published

25 October 2023

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

14 - 2023

Updates

Copyright

*Correspondence: Lori Ferrins Christopher A. Rice

†Present address: Christopher A. Rice, Purdue Institute for Drug Discovery (PIDD), Purdue University, West Lafayette, IN, United States; Purdue Institute of Inflammation, Immunology and Infectious Disease (PI4D), Purdue University, West Lafayette, IN, United States

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics